US EditionDrugmakers to face 100% tariff unless they cut prices or produce drugs in US, Trump administration says
- On Thursday, one year after 'Liberation Day,' President Donald Trump imposed 100 percent tariffs on imported branded pharmaceuticals, targeting companies that have not agreed to lower prices and move production to the United States.
- Trump's administration aims to pressure manufacturers to 'communicate most-favored-nation price targets' and build domestic plants, with large companies facing a 120-day compliance deadline and smaller producers having 180 days before duties apply.
- Separately, Trump revised metals duties, halving tariffs on many steel, aluminum, and copper derivatives to 25 percent while cutting duties on specific industrial equipment to 15 percent to support domestic infrastructure.
- The United States finalized a zero-tariff deal for British-made pharmaceuticals, yet the Chamber's policy chief Neil Bradley warned the scheme will 'raise healthcare costs for American families.'
- U.S. Trade Representative Jamieson Greer defended the tariffs as a 'reset button' for a broken global trading system, following last month's Supreme Court ruling that previous tariffs were unlawful.
191 Articles
191 Articles
Trump’s New Pharma Tariffs Could Drive Up Medical Costs, Patient Advocates Warn
On Thursday, the one-year anniversary of President Donald Trump’s so-called Liberation Day, US advocacy groups sounded the alarm about his new tariffs targeting “patented pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act of 1962 to bolster American national security and public health.” The administration announced a year ago that the US Department of Commerce… Source
Trump threatens up to 100% tariffs on brand-name drugs
President Donald Trump celebrated the anniversary of his 2025 "Liberation Day” tariffs on Thursday by issuing a new executive order imposing more tariffs. This one targets pharmaceutical drugs. Under the new order, brand-name drugs from companies that don’t cut deals with the Trump administration in the coming months could face tariffs of up to 100%. Companies that sign on to the president's “most favored nation” pricing plan and build facilitie…
The U.S. government has increased import duties on drugs.
U.S. customs duties are getting harder on drugs and metals. Washington wants to repatriate pharmaceutical production, with surcharges that can rise to 100%. Commercial allies benefit from the...
United States President Donald Trump on Thursday imposed new tariffs on certain pharmaceuticals and reshuffled tariffs on metals, further tightening his trade policy a year after he launched trade wars with almost all of his partners.
Coverage Details
Bias Distribution
- 45% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
